Enzo prepares trial for new eye drug
Enzo
Enzo BioChem Inc. will begin a clinical trial study of a new drug, Optiquel, for treatment of uveitis, a non-infectious inflammation of the eye, the company said Monday.
Enzo is a Manhattan company with a major division, Enzo Clinical Labs, in Farmingdale.
It said it filed an investigational new drug application with the Food and Drug Administration.
The company described the planned trial as a "randomized, double-masked, placebo-controlled study with a long-term follow-up."
The study will be conducted by the National Institute of Health's National Eye Institute. The principal investigator will be Dr. Robert Nussenblatt, chief of the institute's laboratory of immunology.
Sarra Sounds Off, Season 3, Ep 4: Top football teams in action, fantasy update and plays of the week Gregg Sarra sounds off on the Nassau Conference II football matchup between Calhoun at Carey, plus the comeback story of New Hyde Park's Gabriel Peter, an update on the high school fantasy football standings and the plays of the week.
Sarra Sounds Off, Season 3, Ep 4: Top football teams in action, fantasy update and plays of the week Gregg Sarra sounds off on the Nassau Conference II football matchup between Calhoun at Carey, plus the comeback story of New Hyde Park's Gabriel Peter, an update on the high school fantasy football standings and the plays of the week.
